menu search

Why shares of eyepoint pharmaceuticals were rising monday

eyepoint reported top-line data on two phase 2 trials for its lead pipeline candidate. The company focu...

September 11, 2023, 3:20 pm

eyepoint pharmaceuticals announces participation at upcoming investor conferences

WATERTOWN, Mass., Aug. 30, 2023 (GLOBE NEWSWIRE) -- eyepoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a ph...

August 30, 2023, 7:00 am

eyepoint: well-funded and catalyst-rich, but not without risks

eyepoint Pharmaceuticals is developing the EYP-1901 treatment for wet age-related macular degeneration ...

August 21, 2023, 8:31 am

eyepoint pharmaceuticals to report second quarter 2023 financial results on august 2, 2023

WATERTOWN, Mass., July 26, 2023 (GLOBE NEWSWIRE) — eyepoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a c...

July 26, 2023, 11:00 am

eyepoint pharmaceuticals to report second quarter 2023 financial results on august 2, 2023

WATERTOWN, Mass., July 26, 2023 (GLOBE NEWSWIRE) -- eyepoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a co...

July 26, 2023, 7:00 am

eyepoint pharmaceuticals: a puncher's chance for long acting eye disease drug success

eyepoint is a $200m market cap biotech focused on eye disease. The company's long-acting Durasert techn...

May 30, 2023, 8:00 am

Alimera (alim) up on deal with eyepoint for u.s. rights to yutiq

Alimera Sciences  ALIM announced acquiring additional U.S. commercialization rights for 0.18 mg dose strength of Yutiq from ...

May 19, 2023, 1:46 pm

Why is alimera sciences (alim) stock up 21% today?

Alimera Sciences (NASDAQ: ALIM ) stock is taking off on Thursday after signing a major deal with eyepoint...

May 18, 2023, 10:52 am

eyepoint pharmaceuticals, inc. (eypt) q1 2023 earnings call transcript

eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT ) Q1 2023 Results Conference Call May 3, 2023 8:30 AM ET Co...

May 3, 2023, 11:48 pm

Strength seen in eyepoint pharmaceuticals (eypt): can its 9.6% jump turn into more strength?

eyepoint Pharmaceuticals (EYPT) witnessed a jump in share price last session on above-average trading v...

April 20, 2023, 5:20 am

eyepoint alert: bragar eagel & squire, p.c. is investigating eyepoint pharmaceuticals, inc. on behalf of eyepoint stockholders and encourages investors to contact the firm

NEW YORK, Dec. 16, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized stockholder rights law firm, is investigating potent...

December 17, 2022, 4:03 am

eyepoint pharmaceuticals reports inducement grants under nasdaq listing rule 5635(c)(4)

WATERTOWN, Mass., Dec. 16, 2022 (GLOBE NEWSWIRE) — eyepoint Pharmaceuticals, Inc. (NASDAQ: EYPT), a p...

December 16, 2022, 9:01 pm

Bragar eagel & squire, p.c. is investigating eyepoint, f45, prog, and intuit and encourages investors to contact the firm

NEW YORK, Nov. 11, 2022 (GLOBE NEWSWIRE) — Bragar Eagel & Squire, P.C., a nationally recognized shareholder rights law firm, is investigating potent...

November 12, 2022, 2:00 am

eyepoint pharmaceuticals: key player in the long-acting wet amd space

Shares have lost 15% year to date. Durasert technology has been extensively validated and administered to over 80,000 patient eyes....

August 30, 2022, 12:17 am

eyepoint pharmaceuticals, inc. (eypt) ceo nancy lurker on q2 2022 results - earnings call transcript

eyepoint Pharmaceuticals, Inc. (NASDAQ:EYPT ) Q2 2022 Earnings Conference Call August 3, 2022 8:30 AM E...

August 3, 2022, 3:05 pm

eyepoint pharmaceuticals (eypt) soars 21.6%: is further upside left in the stock?

eyepoint Pharmaceuticals (EYPT) witnessed a jump in share price last session on above-average trading v...

July 18, 2022, 6:13 am

eyepoint, expands pact with betta pharma for eyp-1901 in china, posts deeper q1 loss

eyepoint Pharmaceuticals Inc (NASDAQ: EYPT) executed a license agreement with Betta Pharmaceuticals...

May 4, 2022, 12:22 pm

eyepoint pharmaceuticals, inc. (eypt) ceo nancy lurker on q4 2021 results - earnings call transcript

eyepoint Pharmaceuticals, Inc. (EYPT) CEO Nancy Lurker on Q4 2021 Results - Earnings Call Transcript...

March 3, 2022, 3:10 pm

eyepoint pharmaceuticals, inc. (eypt) ceo nancy lurker on q4 2021 results - earnings call transcript

eyepoint Pharmaceuticals, Inc. (EYPT) CEO Nancy Lurker on Q4 2021 Results - Earnings Call Transcript...

March 3, 2022, 3:10 pm

eyepoint pharmaceuticals, inc. (eypt) ceo nancy lurker on q4 2021 results - earnings call transcript

eyepoint Pharmaceuticals, Inc. (EYPT) CEO Nancy Lurker on Q4 2021 Results - Earnings Call Transcript...

March 3, 2022, 3:10 pm


Search within

Pages Search Results: